BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11712789)

  • 1. A new staging system based on tumor volume in gastric cancer.
    Kikuchi S; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
    Anticancer Res; 2001; 21(4B):2933-6. PubMed ID: 11712789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor volume as an indicator of nodal status in advanced gastric carcinoma.
    Kikuchi S; Matsuzaki H; Kurita A; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
    In Vivo; 2001; 15(4):295-8. PubMed ID: 11695220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with pN3 stage tumors according to the TNM classification in advanced gastric cancer.
    Kikuchi S; Katada N; Sakuramoto S; Koabayashi N; Shimao H; Sakakibara Y; Kakita A
    Hepatogastroenterology; 2003; 50(53):1723-6. PubMed ID: 14571827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients.
    Landry CS; Brock G; Scoggins CR; McMasters KM; Martin RC
    Ann Surg Oncol; 2009 Jan; 16(1):51-60. PubMed ID: 18953609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
    Smith DD; Schwarz RR; Schwarz RE
    J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumor size in T3 gastric cancer.
    Liu X; Xu Y; Long Z; Zhu H; Wang Y
    Ann Surg Oncol; 2009 Jul; 16(7):1875-82. PubMed ID: 19373514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.
    Schwarz RE; Smith DD
    Ann Surg Oncol; 2007 Feb; 14(2):317-28. PubMed ID: 17094022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients.
    Landry CS; Brock G; Scoggins CR; McMasters KM; Martin RC
    J Am Coll Surg; 2008 Dec; 207(6):874-81. PubMed ID: 19183534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
    Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
    Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
    Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
    J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)].
    Gao JM; Zeng YX; Cui NJ; Lu TX; Zhao C; Xia YF; Ma J; Xie FY
    Ai Zheng; 2005 Oct; 24(10):1165-72. PubMed ID: 16219127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer.
    Nakamura K; Ozaki N; Yamada T; Hata T; Sugimoto S; Hikino H; Kanazawa A; Tokuka A; Nagaoka S
    Surgery; 2005 May; 137(5):511-7. PubMed ID: 15855922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
    Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinical evaluation of patients with T2 gastric cancer.
    Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor diameter as a prognostic factor in patients with gastric cancer.
    Kunisaki C; Makino H; Takagawa R; Oshima T; Nagano Y; Kosaka T; Ono HA; Otsuka Y; Akiyama H; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Jul; 15(7):1959-67. PubMed ID: 18369676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.
    Li C; Yan M; Chen J; Xiang M; Zhu ZG; Lin YZ
    J Surg Oncol; 2009 May; 99(6):324-8. PubMed ID: 19204941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of lymph node staging in gastric cancer.
    Ichikawa D; Kurioka H; Ueshima Y; Shirono K; Kan K; Shioaki Y; Lee CJ; Hamashima T; Deguchi E; Ikeda E; Mutoh F; Yamagishi H
    Hepatogastroenterology; 2003; 50(49):301-4. PubMed ID: 12630046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of total retrieved lymph nodes on staging and survival of patients with gastric cancer invading the subserosa.
    Liu C; Lu Y; Jun Z; Zhang R; Yao F; Lu P; Jin F; Li H; Xu H; Wang S; Chen J
    Surg Oncol; 2009 Dec; 18(4):379-84. PubMed ID: 18954972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.